Study reveals how bile acids impact immunotherapy in liver cancer
Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors. It...
Immunotherapy
Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can’t be treated with surgery | Health and Wellness News
Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the...
Neoadjuvant Immunotherapy Improves Outcomes in Treatment of High-risk Liver Cancer
Patients diagnosed with liver cancer (hepatocellular carcinoma; HCC) who received immune checkpoint inhibitors (ICIs) before surgery—including those who would not...
Imfinzi-Imjudo dual immunotherapy offers new option for 1st-line treatment of liver cancer < Pharma < Article
As AstraZeneca launches Imjudo (tremelimumab) without health insurance coverage in May, Korean liver cancer patients will likely have...
Adding Immunotherapy to Local Treatment Delays Liver Cancer Progression
Adding the immune checkpoint inhibitor Imfinzi (durvalumab) and the VEGF inhibitor Avastin (bevacizumab) to transarterial chemoembolization (TACE) led to improved...
